INTERNATIONAL CONFERENCE ON ADVANCEMENT OF BIOTECHNOLOGY IN HEALTHCARE, BIOPRODUCTS AND ENVIRONMENTAL RESEARCH-2026
(CABHBE-2026)
Date-10th -12th December 2026
Organized by
Department of Biotechnology in Association with DBT-BIRAC E-YUVA Center
GIET University, Odisha, Gunupur
About the GIET University:
GIET University, Gunupur (formerly known as Gandhi Institute of Engineering and Technology) was established by “Vidya Bharati Educational Trust,” Gunupur, Odisha, India in the year 1997. Since inception, the Trust promotes Technical Education in India with a motto of providing Quality Education in a highly disciplined and conducive environment with International Standards. GIET University, Gunupur -A tranquil paradise, away from the noise and bustle of an urban area, surrounded by lush greenery and nestled in the beautiful foothills of eastern India. This is one of the most prestigious universities of India. It has come out as the top in eastern India because of many reasons: 26 years pioneering educational establishment and a great temple of learning, which has welcomed intellectual, cultural and social giants from the length and breadth of the country who left indelible footprints on the sands of time making GIET University a proud alma-mater. There are more than 3,780 students at GIET University, Gunupur with combination of graduates and postgraduates. High discipline: 100% ragging free environment with zero loss of working days and also 300+ top class faculty, attractive campus of 113.03 acres, incomparable infrastructure with 110 laboratories, 4 state-of-art workshop, 20 high end computer labs and 64 modern classrooms and 7 air conditioned auditoriums and best hostels having 2817 boarders of 12 boys hostel and 11 girls hostel with generator backup, Wi-Fi internet & 24hrs security system. Currently, university offers admissions to various UG, PG & Doctoral program in of various discipline and specialization like Computer Engineering, Electronics and Communication Engineering. The Institute faculty members are highly dedicated to carrying out interdisciplinary researches and design-oriented projects in line with the mission and vision of the University.
Department of Biotechnology: The Department of Biotechnology was established in the year 2003. The vision and mission of the department is pursuance for excellence toachieve sustainable development and to impact training for capacity building to take focused research and product development in frontier areas of Biotechnology. The department is accredited by NBA. It offers Ph.D, M. Tech, M.Sc and B.Tech programs. The department promotes innovation, entrepreneurship, and independent projects, with opportunities to work on funded research..
About BIRAC E-YUVA Center, GIET University: The BIRAC E-YUVA Center at GIET University is a dedicatedbiotechnology pre-incubation hub established with the support of the Biotechnology Industry Research Assistance Council (BIRAC), Government of India. The center aims to ignite young minds, particularly undergraduate, postgraduate students, and post doctoral student by nurturing innovative, problem-solving ideas in life sciences, agriculture, healthcare, and biotechnology. Equipped with modern laboratories, mentorship support, fellowship, seed funding opportunities, and structured training programs, the E-YUVA Center enables early-stage innovators to transform their concepts into proof-of-concept prototypes.
About Conference: CABHBE-2026, organized by the Department of Biotechnology, GIET University, Gunupur, Odisha, marks the second edition of the International Conference on Advancement of Biotechnology in Healthcare, Bioproducts and Environmental Research. Scheduled for 10–12 December 2026, the conference is envisioned as a multidisciplinary platform bringing together academic scientists, faculty members, research scholars, industry leaders, healthcare professionals, technologists, entrepreneurs, innovators, policymakers, environmental scientists, government representatives, and students from across the biotechnology, healthcare, environmental, and life science sectors. Designed to facilitate high-impact national and global collaborations, CABHBE-2026 aims to connect universities, research institutions, healthcare organizations, industries, startups, and innovation ecosystems to exchange scientific knowledge, showcase cutting-edge research and Innovations, and foster technology-driven partnerships. The conference emphasizes advancements in healthcare biotechnology, bioproduct development, environmental sustainability, industrial biotechnology, biomedical innovations, and translational research, promoting the translation of scientific discoveries into sustainable technologies and real-world solutions while strengthening innovation, entrepreneurship, and academia–industry collaboration for societal and economic impact.
Conference Overview
The International Conference on Biomedical Innovation, Ownership and Intellectual Property (ICBIOIP 2026) brings together global leaders from academia, industry, government, and international organizations to explore the evolving landscape of biomedical innovation and intellectual property (IP).As scientific breakthroughs accelerate—from genomics and AI-driven diagnostics to vaccines and personalized medicine—the questions of ownership, access, ethics, and IP governance have never been more critical. This conference provides a multidisciplinary platform to exchange ideas, present cutting-edge research, and shape future policy. Many developmental and stem cell biologists will be familiar with writing grant applications that discuss how their fundamental research findings might translate into discoveries that improve health and society, but what is really involved in this process? In this Perspective, we hear from the six researchers who have transitioned from academia to industry to help guide the development of four bioscience companies. We learn how they have navigated the opportunities and pitfalls of patents, intellectual property, investors and biotechnology start-ups to bring new biological advances from the bench and into the boardroom. Artificial Intelligence (AI) has revolutionized the biomedical sector in advanced diagnosis, treatment, and personalized medicine. While these AI-driven innovations promise vast benefits for patients and service providers, they also raise complex intellectual property (IP) challenges due to the inherent nature of AI technology. We shall be discussed the multifaceted impact of AI on IP within the biomedical sector, exploring implications in areas like drug research and discovery, personalized medicine, and medical diagnostics. We dissect critical issues surrounding AI inventorship, patent and copyright protection for AI-generated works, data ownership, and licensing. To provide context, we analysed the current IP legislative landscape in the Indian Context, highlighting convergences, divergences, and precedent-setting cases relevant to the biomedical sector. Recognizing the need for harmonization, we reviewed current developments and discussed a way forward. We advocate for a collaborative approach, convening policymakers, clinicians, researchers, industry players, legal professionals, and patient advocates to navigate this dynamic landscape. It will create a stable IP regime and unlock the full potential of AI for enhanced healthcare delivery and improved patient outcomes. This webinar provides a clear, practical framework for using AI responsibly across the research lifecycle. We will explore how to evaluate AI-generated content, prevent inaccuracies and hallucinations, ensure transparency in AI-assisted writing, safeguard sensitive data, and recognise potential bias in AI outputs. Participants will also gain insights into global guidelines from COPE, and major publishers, alongside Clarivate’s innovations in the responsible AI space. Designed for faculty, researchers, librarians, and students, the session aims to equip institutions with the awareness needed to build a culture of ethical, accountable, and trustworthy AI use in academia.
Conference Objectives
● Foster interdisciplinary collaboration in biomedical research
● Showcase cutting-edge technologies and clinical breakthroughs
● Bridge the gap between laboratory research and patient care
● Promote ethical, sustainable, and inclusive healthcare innovation
● Encourage young researchers and start-ups in biomedical sciences
Conference Themes & Tracks / Focus Area
Track 1: Biomedical Engineering & Medical Devices
● Smart implants and prosthetics
● Wearable health monitoring systems
● Robotics and automation in surgery
● Point-of-care diagnostic devices
Track 2: Artificial Intelligence & Digital Health
● AI and machine learning in medical imaging
● Clinical decision support systems
● Digital twins in personalized medicine
● Telemedicine and remote patient monitoring
● Introduction to Responsible AI in Research
● Understanding AI Capabilities and Limitations
● Ensuring Research Integrity in AI-Assisted Workflows
● Data Privacy, Security, and Sensitivity in AI Tools
● Ethical Literature Search and Review Practices
● AI-Assisted Writing: Transparency and Attribution
● Avoiding Bias and Ensuring Fairness in AI Outputs
● Using AI for Research Design and Analysis Responsibly
● Evaluating AI Tools for Trustworthiness
●
● Institutional Policies and Global Guidelines on AI Use and Building a Responsible AI Culture in Academic Institutions
Track 3: Biotechnology & Molecular Medicine
● Gene editing and CRISPR technologies
● Stem cell therapy and regenerative medicine
● Biomarkers and precision diagnostics
● Vaccine development and immunotherapy
Track 4: Digital Image Processing
● Artificial Intelligence
● Machine Learning
● Soft Computing Techniques
Track 5: Drug Discovery & Translational Research
● Computational drug design
● Nanomedicine and targeted drug delivery
● Clinical trials innovation
● From bench to bedside: translational strategies
Track 6: Bioinformatics & Systems Biology
● Multi-omics data integration
● Predictive modeling of diseases
● Big data analytics in healthcare
● Cloud computing for biomedical research
Track 7: Public Health, Ethics & Regulatory Science
● Ethical challenges in biomedical innovation
● Data privacy and cybersecurity in healthcare
● Regulatory pathways for medical products
● Global health equity and accessibility
Track 8: Graduate, Post Graduate, Research Scholar
● Paper presentation with respective fields
● Research Methodology
● Intellectual Property Right
● Innovations
● Translational Research
Track 9: Graduate, Post Graduate, Research Scholar
Advanced Molecular Biology
DNA structure and function
Gene regulation and expression
Recombinant DNA technology
Genome sequencing and bioinformatics
Cell Biology
Cell structure and organelles
Signal transduction
Cell division and apoptosis
Stem cells and regenerative biology
Biostatistics and Bioinformatics
Statistical analysis in biology
Software tools for biological data analysis (e.g., R, SPSS, Python for Bioinformatics)
Introduction to genomic data analysis
Phylogenetic trees and protein structure prediction
Biochemistry
Enzyme kinetics and mechanisms
Metabolic pathways (Glycolysis, Krebs Cycle, etc.)
Protein structure, folding, and function
Lipids and carbohydrates in cell functions
Genetics
Mendelian genetics and beyond
Molecular genetics and gene editing (CRISPR/Cas9)
Population genetics and evolution
Human genetics and genetic diseases
Microbiology
Microbial taxonomy and diversity
Host-pathogen interactions
Microbial genetics and genomics
Immunology and antimicrobial resistance
Environmental Biology
Ecology and ecosystems
Biodiversity conservation
Climate change and its biological impacts
Environmental microbiology
Research Methodology and Scientific Communication
Experimental design and techniques
Data analysis and interpretation
Writing research papers and grant proposals
Presenting scientific findings (Oral and Poster presentations)
Advanced Biotechnology
Genetic engineering and GMOs
Biotechnology applications in medicine (e.g., vaccine development)
Agricultural biotechnology
Bioreactors and industrial microbiology
Immunology
Immune system components and function
Immunodeficiencies and autoimmune diseases
Vaccine development and immunotherapies
Cancer immunology
Neurobiology
Neural signaling and neurotransmission
Brain structure and function
Neurodegenerative diseases (e.g., Alzheimer's, Parkinson's)
Neuroplasticity and learning
Bioethics and Biosafety
Ethical issues in research (e.g., cloning, genetic testing)
Clinical trials and regulatory guidelines
Biosafety in laboratories and industries
Environmental and social impacts of biotechnologies
Dissertation/Research Project
Students are expected to conduct independent research on a topic of their choice (under supervision).
Analysis, experimentation, data collection, and writing of a dissertation.
Elective Courses
Depending on the program, students can choose specialized electives, such as:
Cancer Biology
Computational Biology
Structural Biology
Marine Biology
Plant Biotechnology
Seminar Presentations
Students may be required to present their research findings in the form of seminars.
Lab Skills: Hands-on experience with PCR, Western blotting, cell culture, chromatography, etc.
Research Skills: Critical thinking, experimental design, and data analysis.
Scientific Writing and Communication: Writing papers, theses, and presenting scientific data.
Research Scientist (Academia or Industry)
Biotech/Pharmaceutical Industry Professional
Environmental Consultant
Medical Researcher
Bioinformatician
Clinical Research Coordinator
Forensic Scientist
Track 10: Graduate, Post Graduate, Research Scholar
Cell Biology & Development
🔹 Principles of Molecular Genetics / Molecular Biology
🔹 Biological/Biological Chemistry & Metabolic Regulation
🔹 Microbiology & Microbial Technology
🔹 Biostatistics / Bioanalytical Techniques
🔹 Laboratory Practical: Cell Biology, Molecular Techniques, Microbiology
👉 Focus: core biology, cells, genes, proteins, microbes, and basic lab skills.
🔹 Immunology & Immunotechniques
🔹 Recombinant DNA Technology & Genetic Engineering
🔹 Bioinformatics & Computational Biology
🔹 Plant Biotechnology / Principles of Plant Science
🔹 Practical Work: Molecular & Immunology Labs, Bioinformatics
🔹 Research Methodology basics
👉 Focus: immune systems, cutting-edge genetic tools, data analysis.
🔹 Animal Biotechnology
🔹 Bioprocess Engineering & Fermentation Technology
🔹 Environmental/Industrial Biotechnology
🔹 Electives (may include):
• Nanobiotechnology
• Proteomics & Genomics
• Medical/Pharmaceutical Biotechnology
• Stem Cell Biology
🔹 Practical Work & Group Project
👉 Focus: industrial applications, advanced lab & elective topics.
🔹 Genomics & Proteomics
🔹 Biochemical & Biophysical Techniques
🔹 Intellectual Property Rights / Biosafety / Ethics
🔹 Dissertation / Project Work & Viva
🔹 Industrial/Research Internship
👉 Focus: specialized techniques, research experience, industry exposure.
● Advanced Cell & Molecular Biology
● Biochemistry and Enzyme Technology
● Genetics & Genetic Engineering
● Microbiology & Immunology
● Bioinformatics and Computational Biology
● Bioprocess Engineering & Fermentation
● Plant & Animal Biotechnology
● Environmental and Industrial Biotechnology
● Research Methodology & Biostatistics
● Ethics, IPR & Biosafety
● Hands-on Laboratory Techniques
Biotechnology master’s programs have a strong lab component, including experiments on:
● DNA/ RNA isolation, PCR, gene cloning
● Protein purification & enzyme assays
● Cell & tissue culture
● Bioinformatics software and sequence analysis
● Bioprocessing experiments
👉 Final projects and internships are often part of all Semester .
Drug design, synthetic biology, medical biotech, etc.
` Keynote Topics (Sample)
● The Future of Precision Medicine
● AI-Driven Healthcare: Opportunities and Risks
● Innovations in Regenerative Medicine
● Biomedical Innovation for Sustainable Healthcare Systems
● Biomedical Engineering
● Science and Technology
● Engineering and Technology
● Pharmacy
● Nursing
● Medicine
● Surgery
● Hands-on workshop on AI tools for biomedical research
● Startup and industry-academia collaboration forum
● Grant writing and funding opportunities in biomedical science
● Young Researchers and PhD Colloquium
● Original research papers
● Review articles and case studies
● Clinical and industrial innovations
● Accepted papers published in reputed indexed journals / conference proceedings
● Biomedical researchers and scientists
● Medical professionals and clinicians
● Engineers and technologists
● Industry experts and entrepreneurs
● Policymakers and regulatory authorities
● Graduate students and early-career researchers
● Knowledge exchange and global networking
● Research collaborations and partnerships
● Translation of innovation into clinical practice
● Policy and regulatory insights
● Empowerment of emerging biomedical innovators
🔬 Biomedical Innovation
● Translational research and commercialization
● Emerging technologies in biotechnology and healthcare
● AI, genomics, and digital health innovations
⚖️ Intellectual Property & Law
● Patent systems in biotechnology and pharmaceuticals
● Trade secrets, data exclusivity, and regulatory protection
● International IP frameworks (TRIPS, WIPO, WTO)
🌍 Ownership, Ethics & Access
● Ownership of genetic data and biological materials
● Equity, access to medicines, and global health justice
● Ethical challenges in biomedical IP
🏭 Industry & Technology Transfer
● University–industry collaboration
● Licensing, startups, and spin-offs
● Valuation and management of biomedical IP
📜 Policy & Governance
● Public-private partnerships
● Innovation policy and global health emergencies
● IP reform for sustainable innovation
NB: This track is a general syllabus, and depending on your focus (such as in microbiology, molecular biology, or bioinformatics), the subjects may differ. Some programs may also offer opportunities for internships or industry collaborations as part of the curriculum.
Host Organization(s):
Gandhi Institute of Engineering and Technology University, Gunupur, Rayagada, Odisha – 765 022
Dates & Venue (physical / virtual / hybrid): Date-22nd -25nd Feb,Gandhi Institute of Engineering and Technology University, Gunupur, Rayagada, Odisha – 765 022
Official Language(s): English and Hindi
Target Audience (academics, industry, policymakers, students): 10000
Keynote Speakers (Tentative)
● Prof. Maria Sanchez, Global Health Law, WHO
● Dr. Alan Robertson, Chief Innovation Officer, BioTech Global
● Prof. Li Wei, Intellectual Property & Biotechnology, Tsinghua University
● Dr. Amina El-Sayed, Ethics of Biomedical Innovation, UNESCO
● Prof. Ashan Rizvi, USA
● Prof. Anupama Numbru, JNU
Who Should Attend
● Researchers & Academicians
● Biomedical & Pharmaceutical Professionals
● IP Lawyers & Patent Agents
● Policymakers & Regulators
● Technology Transfer Officers
● Startup Founders & Investors
● Postgraduate & Doctoral Students
● BTec. MTech,, BSc. Nursing, MSc. Nursing
● Pharmacy, MBBS, MD, BDS,MDS and Paramedical Sciences
● All disciplines of Engineering and Technology
Call for Papers
We invite original research papers, case studies, policy analyses, and review papers related to the conference themes.
Call for Paper Started: 14 February 2026
📌 Submission Deadline: 18 February 2026
📌 Notification of Acceptance: 20 February l 2026
📌 Camera-Ready Submission: 21 February 2026
✔ Selected papers will be published in indexed conference proceedings and partner journals/Text Book.
Conference Highlights
✨ Keynote & Plenary Sessions
✨ Panel Discussions with Global Experts
✨ Paper & Poster Presentations
✨ IP & Innovation Workshops
✨ Networking & Collaboration Sessions
✨ Best Paper & Young Researcher Awards
Registration Categories
Category
Early Bird Regular Indian
Academicians/Professionals USD 350 USD 450 3000.00
Students/Research Scholars USD 200 USD 300 2000.00
Virtual Participants USD 200 USD 300 2000.00
Organizational Structure
● Patron / Chief Guest
● Conference Chair / Co-Chair
● Organizing Committee
● Scientific / Technical Committee
● Advisory Board
● Review Committee
Be part of a global dialogue shaping the future of biomedical innovation, ownership, and intellectual property—where science meets law, ethics, and society.
🌍 Innovate. Protect. Share and Hands on.
Just tell me the purpose and audience.
Program Structure
Day-wise Format (Typical)
Inaugural Session
● Welcome Address
● Opening Remarks
● Keynote Address
● Guest of Honor Speech
● Conference Overview
Technical Sessions
● Oral Presentations
● Parallel Sessions / Tracks
● Panel Discussions
● Workshops / Tutorials
Poster Sessions
● Scheduled viewing time
● Presenter interaction
Plenary / Keynote Sessions
● Renowned international speakers
● Cross-disciplinary topics
Special Sessions
● Industry–Academia Meet
● Roundtable Discussions
● Student Research Forum
Valedictory / Closing Session
● Summary of outcomes
● Awards & Certificates
● Vote of Thanks
Paper & Presentation Format
Paper Submission as per the standard given below:
● Abstract (200–300 words)
● Full Paper (6–10 pages)
● Standard Templates (IEEE / Springer / ACM, etc.)
● Peer-review process (single-blind / double-blind)
Presentation
● Oral: 10–15 min presentation + Q&A
● Poster: A0 or A1 size (or digital posters for virtual)
Registration Structure
● Early Bird / Regular / Late Registration
● Categories:
o International Delegates
o Domestic Delegates
o Students / Research Scholars
o Industry Participants
Proceedings & Publications
● ISBN/ISSN Proceedings
● Indexed Journals (Scopus / Web of Science, if applicable)
● Digital Library Access
Networking & Cultural Elements
● Welcome Reception
● Conference Dinner / Cultural Program
● Exhibition / Sponsor Booths
● Networking Breaks
Virtual / Hybrid Conference Additions
● Time-zone adjusted schedule
● Live streaming & recordings
● Online Q&A & chat rooms
● Virtual poster halls
Conclusion/Outcome:
The International Conference on Biomedical Innovation, Ownership and Intellectual Property (ICBIOIP 2026) aims to shape the future of healthcare by fostering collaboration across disciplines and borders. By uniting innovation, ethics, and technology, the conference contributes to improving global health outcomes. we participate in the entire spectrum of translational research, but our focus is in the areas of basic research and new methods to prevent, diagnose, and treat disease, extending to proof of concept preclinical and Phase 1 studies. Since we believe that all phases of translational research should have an equity lens, we have instituted an initiative to encourage thought and planning about global equitable access to discoveries made by our trainee Clinical Scholars and faculty, even at the earliest phases of basic research. Assuring global equitable access to new technologies requires addressing at least 3 different aspects of new technology: Patenting and licensing, Manufacturing, and Dissemination and implementation in low- and middle-income countries. In this review, I focus on patenting and licensing and offer ten questions for inventors to consider in discussing licensing their technologies with technology transfer officers to maximize equitable global access to the technologies they create. The framework offers a structured and systematic approach for identifying data on public and philanthropic contributions to developing medical products (medicines and devices). This information is often not comprehensively documented. Therefore, aligned public policies enforcing transparent and standardized reporting in sufficient granularity on R&D investments and conditions are key. This International Conferences addresses the question of the possibility of medical research without patents, a major issue in healthcare research and policy. We discuss and evaluate the relevant scientific, economic, societal, and moral aspects of our system of funding and organizing the research, development, manufacture and sale of prescription drugs. The focus is on the patent practices of big pharmaceutical companies. We analyze and critically assess the main features and impacts of these practices. In a positive sense, we propose an approach to organizing and funding drug research that prioritizes its public interest rather than its privatization through patenting. For these purposes, we first demonstrate that producing prescription drugs through patenting has serious drawbacks. Second, we develop a concrete alternative (medical research without patents) that is shown to be scientifically, socially and morally preferable, economically and financially profitable, and socio-politically and organizationally practicable.
Contact:
Prof. (Dr.) Mayadhar Barik, AIIMS, Sir APJ Abdul Kalam, Tejaswini & Excellence in Research Awardee , Convenor & Advisor BIOTRIP-2026,
Dean R&D, BioMedical Sciences, GIET University, Gunupur-765022, Odisha, India
Email: biotripgietu@gmail.com,
📞 Phone: +91-70 0892 3339
